Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature

Conclusion: The clinical spectrum of Anti-IgLON5 disease continues to expand. Further studies are needed to elucidate the pathophysiology, therapeutic strategies and outcome in this novel disorder. Aggressive immunotherapy seems to increase survival.
Source: Frontiers in Neurology - Category: Neurology Source Type: research